Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Body "iron stores" represent a dynamic reservoir managed primarily by ferritin and hemosiderin within organs like the liver, spleen, and bone marrow. These reserves ensure continuous supply for essential functions such as oxygen transport, enzyme activity, and immune support, while protecting against toxicity from free circulating iron through tight regulatory mechanisms involving hepcidin and cellular sensors responsive to systemic needs. Maintaining adequate but not excessive iron stores is vital for overall health. Imbalances can lead to iron deficiency anemia (low stores) or conditions like hemochromatosis (high stores).
N/A - Iron stores are a physiological system, not a single druggable target. Interventions target individual components of the system (e.g., iron absorption, storage, release). Iron supplements increase iron availability, chelators bind and remove excess iron, hepcidin mimetics reduce iron release.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron Stores (Body).